Nicotine - Retracted Studies, Papers, and Articles
Retractions
2022: Original: Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study
- 2023: Retraction Notice to “Association of Smoking and E-Cigarette in Chronic Liver Disease: An NHANES Study”
- Media - Filter: Journal Retracts Study That Linked Vaping to Liver Disease
2022: Original: Cancer Prevalence in E-Cigarette Users: A Retrospective Cross-Sectional NHANES Study
2019: Original: Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health
How Mistakes Can Happen
2022: Cross‑sectional e‑cigarette studies are unreliable without timing of exposure and disease diagnosis
- "Studies based on cross-sectional data with no information on age of e-cigarette initiation and age of diagnosis invariably overestimate associations by including cases that were diagnosed before e-cigarette exposure. Although the authors of those studies did not make causal claims in the reports, university media releases and subsequent media articles invariably misled the public to believe that e-cigarette use increases risk for diseases."
- Citation: Rodu B, Plurphanswat N. Cross-sectional e-cigarette studies are unreliable without timing of exposure and disease diagnosis. Intern Emerg Med. 2023 Jan;18(1):319-323. doi: 10.1007/s11739-022-03141-3. Epub 2022 Nov 25. PMID: 36434423.
2022: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research
- Conclusion: "Our critical appraisal reveals common, preventable flaws, the identification of which may provide guidance to researchers, reviewers, scientific editor, journalists, and policy makers. One striking result of the review is that a large portion of the high-ranking papers came out of US-dominated research institutions whose funders are unsupportive of a tobacco harm reduction agenda..."
- Citation: Hajat C, Stein E, Selya A, Polosa R; CoEHAR study group. Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research. Intern Emerg Med. 2022 Apr;17(3):887-909. doi: 10.1007/s11739-022-02967-1. Epub 2022 Mar 24. Erratum in: Intern Emerg Med. 2022 Aug;17(5):1561. PMID: 35325394; PMCID: PMC9018638.
Retraction/Correction Requests/Comments by Experts
- Note: Dates denote when comments were published, not the paper's publication date.
2022: E-cigarette use is associated with a self-reported diagnosis of prediabetes in never cigarette smokers: Results from the behavioral risk factor surveillance system survey
2022: Tests for confounding with cigarette smoking in the association of E-cigarette use with respiratory disorder: 2020 National-Sample Data
2022: Association Between E-Cigarette Use and Cardiovascular Disease Among Never and Current Combustible-Cigarette Smokers
2022: E-cigarette use and respiratory disorder in an adult sample
2022: Cardiovascular Outcomes Associated With Adult Electronic Cigarette Use
2020: Risk of Stroke With E-Cigarette and Combustible Cigarette Use in Young Adults
2020: Association Between Electronic Cigarette Use and Myocardial Infarction
2019-2020: Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis
2017: Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts
2016: Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner
Expressions of Concern (By Journal Staff)
Suggestions to add to this page
